Surgery
Volume 131, Issue 6 , Pages 636-643 , June 2002

The role of operations for distantly metastatic well-differentiated thyroid carcinoma

,Accepted 11 March 2002.

References 

  1. Shaha A, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg. 1997;174:474–476
  2. Beierwaltes WH, Nishiyama RH, Thompson NW, et al.  Survival time and “cure” in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med. 1982;23:561–568
  3. Niederle B, Roka R, Schemper , et al.  Surgical treatment of distant metastases in differentiated thryoid cancer: indication and results. Surgery. 1986;100:1088–1097
  4. Stojadinovic A, Ghossein RA, Hoos A, et al.  Hürthle cell carcinoma: a critical histopathological appraisal. J Clin Oncol. 2001;19:2616–2625
  5. Schlumberger M, Tubiana M, De Vathaire F, et al.  Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1986;63:960–967
  6. Tubiana M, Haddad E, Schlumberger M, et al.  Long term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985;55:794–802
  7. Schlumberger M, Casara D, Rubello D, et al.  Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med. 1993;34:1626–1631
  8. Pelikan DMV, Lion HL, Hermans J, et al.  The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma. Clin Endocrinol. 1997;47:713–720
  9. Leeper RD. The effect of 131-I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J Clin Endocrinol Metab. 1973;36:1143–1152
  10. Krishnamurthy GT, Bland WH. Radioiodine I-131 therapy in the management of thyroid cancer. A prospective study. Cancer. 1977;40:195–202
  11. Pittas AG, Adler M, Fazzari M, et al.  Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid. 2000;10:261–268

☆ Reprint requests: Ronald A. Ghossein, Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021.

PII: S0039-6060(02)00007-7

doi: 10.1067/msy.2002.124732

Surgery
Volume 131, Issue 6 , Pages 636-643 , June 2002

Article Tools

* Image Usage & Resolution